Symbio Is Your Dermatology CRO

For more than 25 years, Symbio’s dermatology services have set the standard by which other niche CROs are judged. From formulation development through global clinical trials to final approval, we offer specialized expertise, global reach, and exceptional service that reduce variability, streamline operations, and remove uncertainty.

Our Dermatology Research Experience

Dermatology is our specialty. Our support has led to new drugs and devices for skin conditions such as:

  • Acne
  • Actinic keratosis
  • Alopecia areata
  • Androgenetic alopecia
  • Atopic dermatitis
  • Basal cell carcinomas
  • Common warts
  • Hair regeneration
  • Hidradinitis suppurativa
  • Impetigo
  • Onychomycosis
  • Pruritus
  • Psoriasis
  • Rare disease, including EB, prurigo nodularis, pachyonchia congenita, and Netherton syndrome
  • Rosacea
  • Scar therapy
  • Seborrheic keratosis
  • Secondarily infected skin wounds
  • Tinea pedis
  • Urticaria
  • Vitiligo
  • Wound healing

How Does Symbio Enhance Dermatology Trials?

Symbio takes uncertainty out of dermatology research with:

Impactful expertise and true partnership. Give your trial the Symbio touch.